Clinical Trials Sponsored by CURE

Total 4697 results

Institut Curie

Recruiting

Impact of a Process Optimizing the Decision to Continue or Stop Cancer Treatments in Patients With Advanced Non-small Cell Lung Cancer. (PACT-01)

Carcinoma, Non-Small-Cell Lung | Advanced Cancer

France
Institut Curie

Recruiting

LIquid Biopsy to prEdict Responses To First-line immunotherapY in Metastatic Non-small Cell LUNG Cancer. LIBERTY LUNG (LIBERTYLUNG)

NSCLC Patient in a Metastatic Stage Eligible for First-line Treatment With Immune Checkpoint Inhibitor

France
Institut Curie

Recruiting

Randomized, Multicenter, Phase III Trial to Assess Conformal Post-operative Radiotherapy vs. Surveillance After Complete Resection of Stage II/III Thymoma (RADIO-RYTHMIC)

Thymoma Malignant Recurrent

France
Institut Curie

Recruiting

Early Integration of Supportive Care for Metastatic Uveal Melanoma Patients (EarlyTogether)

Uveal Melanoma

France
Institut Curie

Recruiting

DECLIC Patient Education Program : Assessment Through a Population Health Intervention Research Approach (LE DECLIC EPRI)

Cancer Patients With Cancer Pain

France
Institut Curie

Recruiting

Circulating Tumor DNA for the Early Detection of HPV-positive Pelvic Cancer Relapses (CIRCA-HPV)

HPV Positive Pelvic Cancer

France
Institut Curie

Recruiting

Biological Characterisation of High Risk CHildhood Cancer in Children, Adolescents and Young Adults (MICCHADO) (MICCHADO)

Leukemia | Osteosarcoma | Neuroblastoma | Rhabdomyosarcoma | Central Nervous System Tumor | Ewing Sarcoma Family of Tumors

France
Institut Curie

Recruiting

COsegregation of VARiants in Panel of Genes (COVAR)

Genetic Predisposition | Gene Mutation-Related Cancer

France, Guadeloupe, Martinique, Réunion
Institut Curie

Completed

Study on Skin Toxicities Induced by Cancer Treatments (DERMACLIC)

Breast Cancer | Lung Cancer | Solid Tumor, Adult

France
Institut Curie

Active, not recruiting

Analysis of Circulating Tumor Markers in the Blood (ALCINA) (ALCINA)

Cancer

France
Institut Curie

Completed

Assessment of Response to Neo-adjuvant Chemotherapy for Patients With a Locally Advanced Breast Cancer With 3D Elastography (Shear Wave), (NEO-ELASTO)

Breast Neoplasms

France
Institut Curie

Completed

Management of Pediatric Craniopharyngioma by a Combination of Partial Surgical Resection, and Protontherapy (Craniopharyngioma)

Craniopharyngioma

France
Institut Curie

Completed

Circulating Tumor DNA and Follow-up of BRCA1 Mutation Carriers (CirCa 01)

Women With BRCA1 Germline Deleterious Mutation

France
Institut Curie

Completed

Hyperfractionated Versus Conventionally Fractionated Radiotherapy in Standard Risk Medulloblastoma (SIOP-PNET-4)

Medulloblastoma

France
Institut Curie

Active, not recruiting

Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)

Neuroblastoma | Opsoclonus Myoclonus Syndrome

France, Austria, Italy, Spain, Sweden, Switzerland, United Kingdom
Institut Curie

Terminated

AsiDNA Children, Adolescents and Young Adults (AsiDNA)

Recurrent High-grade Glioma

France
Institut Curie

Completed

COVID-19 Study of the Serological Response Against the Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (CoV-2) Virus in 2 Types of Employees, Hospital and Non-hospital, at Institute Curie and Institute Pasteur (Curie-O-SA)

Volunteers From the Institute Curie and Institute Pasteur Staff Who Are Not Showing Active SARS-CoV-2 Infection

France
Institut Curie

Completed

Study Evaluating Hot Flashes in Hormone Sensitive Breast Cancer (HOTSHOT)

Breast Cancer

France
Institut Curie

Completed

Isolation of Volatile Organic Compounds (VOCs) Related to the Olfactory Signature of Breast Cancer. (KDOGCOV)

Breast Cancer | Surgery

France
Pure Green

Unknown

Using Cannabidiol to Treat Diabetic Peripheral Neuropathy of the Feet

Diabetic Peripheral Neuropathic Pain

United States
Pure Green

Completed

Low Dose of Cannabidiol (CBD) to Treat Mild to Moderate Musculoskeletal Pain

Musculoskeletal Pain

United States
Pure Green

Completed

The Use of a Water Soluble Under the Tongue (Sublingual) CBD Tablet for Treating Pain Associated With Diabetic Peripheral Neuropathy

Diabetic Neuropathies

United States
Institut Curie

Unknown

Study of the Activity of PD-1 Inhibitors in Metastatic Uveal Melanoma (imMUno)

Uveal Melanoma

France
Pure Green

Unknown

Sublingual Tablets With Cannabinoid Combinations for the Treatment of Dysmenorrhea

Fatigue | Nausea | Dysmenorrhea | Headache, Migraine | Mood Disturbance

United States
Institut Curie

Completed

Validity of HER2-amplified Circulating Tumor Cells to Select Metastatic Breast Cancer Considered HER2-negative for Trastuzumab-emtansine (T-DM1) Treatment.

Metastatic Breast Cancer, HER2 Negative Primary Tumor

France
Institut Curie

Completed

Circulating Tumor Cells to Guide Chemotherapy for Metastatic Breast Cancer (CirCé01)

Breast Cancer Ductal Infiltrating Metastatic

France
Institut Curie

Completed

Impact of a Booklet-Question List on Cancer Patients or Their Families Seeking Prognostic Information During a Palliative Care Consultation (QUEPAL)

Metastatic Cancer | Palliative Care

France
Institut Curie

Completed

Characterisation of Biofilm of the Chronic Wounds (Biofilm Plaie)

Chronic Wounds

France
Institut Curie

Completed

Evaluation of Plasma Alcohol Concentration in Patients Receiving Paclitaxel or Docetaxel (ALCOOTAX)

Tumors

France
Vita Care

Unknown

Anterior Cruciate Ligament Reconstruction Using Single Bundle and Double Bundle Techniques (KR)

Anterior Cruciate Ligament Injury

Brazil
Institut Curie

Not yet recruiting

Patient Experience and Quality of Life During the Surveillance Phase of Uveal Melanoma: A Prospective Multi-method Study (SALOME Quali)

Uveal Melanoma
Institut Curie

Recruiting

Study for the Reliability and Validity of the EORTC PATSAT-C33 and the EORTC OUT-PATSAT7 Questionnaires (PATSAT)

Cancer

France
Institut Curie

Recruiting

Digital Phenotyping in Women Over 70 Years of Age Treated for Breast Cancer With Any Type of Treatment (GrannyFit)

Breast Cancer

France
Institut Curie

Recruiting

Characterisation of the Immune Infiltrate and Molecular Features of Thymic Epithelial Tumors Tumors (TETs) (IMMUNO-TET)

Cancer

France
Institut Curie

Recruiting

Personalized First-line Chemotherapy Choice in Advanced Pancreatic Adenocarcinoma Using Transcriptomic Signatures (PACsign)

Carcinoma, Pancreatic Ductal | Prognosis

France
Institut Curie

Recruiting

ProActIF-01 Trial: Randomized Study of Evaluation of an Individualized Program of Nutrition and Adapted Physical Activity in Frail Patients With Advanced Lung or Digestive Cancers (ProActIF-01)

CANCER

France
Institut Curie

Recruiting

Opioid Free Versus Opioid Based Anaesthesia for Free Flap Reconstruction Surgery of the Breast: A Phase III Multicentric Randomized Controlled Study. (OFOBA)

Breast Cancer

France
Institut Curie

Recruiting

Comparative Study of Diagnostic and Prognosis Biomarkers of Prostate Cancer in Liquid Biopsy (HOPE)

Prostate Cancer | Healthy Donors

France
Institut Curie

Recruiting

Analysis of Circulating Tumor mArkers in Blood 4 - ALCINA 4 (ALCINA4)

Cancer

France
Pure Green

Recruiting

Cannabinoid Tablets for the Treatment of Pain From Osteoarthritis of the Knee

Osteoarthritis, Knee

United States
Institut Curie

Recruiting

Exenteration: Quality of Life Study and Rehabilitation Rate According to the Reconstruction Technique (ETRE) (ETRE)

Cancer

France
Institut Curie

Recruiting

Real Life Study Evaluating the Clinical and Organisational Impact of Moovcare® Lung Connected Medical Device in Lung Cancer Patients : REAL-MOOV-LUNG (REAL-MOOV-LUNG)

Lung Cancer

France
Institut Curie

Recruiting

First-in-human Phase I to Evaluate PEP-010 as Single Agent and in Combination With Paclitaxel or With Gemcitabine (CleverPeptide)

Metastatic Solid Tumor Cancer

France
Institut Curie

Recruiting

Chemotherapy Monitoring by ctDNA in HER2- Metastatic Breast Cancer (MONDRIAN)

HER2-negative Metastatic Breast Cancer

France
Institut Curie

Recruiting

Prospective Biobanking Study in Ovarian, Breast, Head and Neck and Cervical Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE) (SCANDARE)

Cervical Cancer | Head and Neck Cancer | Ovarian Cancer | Triple-Negative Breast Cancer

France
Institut Curie

Terminated

Study to Assess the Impact of Personalized Coaching on the Time Period and Quality of Return to Work After Breast Cancer (OPTICOACH)

Breast Cancer | Surgery

France
Institut Curie

Active, not recruiting

SHIVA02 - Evaluation of the Efficacy of Targeted Therapy Based on Tumor Molecular Profiling in Patients With Advanced Cancer Using Each Patient as Its Own Control (SHIVA02) (SHIVA02)

Cancer | Solid Tumor, Adult

France
Institut Curie

Active, not recruiting

The Integrated Support and Palliative in Cancer Day-care Hospital for Patients With Advanced Cancers: Impact on Quality of Life, Care Pathways and Support for Caregivers (HDJ-SPI)

Cancer, Advanced

France
Institut Curie

Active, not recruiting

Improvement of Local Control in Skull Base, Spine and Sacral Chordomas Treated by Surgery and Protontherapy Targeting Hypoxic Cells Revealed by [18F]FAZA) PET/CT Tracers (PROTONCHORDE01)

Skull Base Chordoma | Vertebral Chordoma

France
Institut Curie

Completed

Use of Specific Genetic Alteration s of Tumoral Cells Identified by the Next Generation Sequencing Techniques (NGS) to Follow Peripheral Samples of Children With Metastatic and/or High Risk Solid Tumor - NGSKids (NGSKids)

Metastatic and/or High Risk Solid Tumor of Children

France

3

Subscribe